SightGlass Vision Strengthens Leadership in Myopia Control Efforts With Two Key Executive Appointments

DALLAS—SightGlass Vision, a joint venture of CooperVision, Inc. and EssilorLuxottica focused on developing science-based treatments for the global myopia epidemic, has enhanced its investment in medical and professional affairs with two key leadership appointments, effective immediately. David Webley has been named senior director, clinical, medical and professional affairs, and Fabio Carta has taken on the new position of director, professional affairs. These appointments are aimed at strengthening SightGlass Vision's connections with the worldwide eyecare community and boosting support and education regarding their DOT myopia control spectacle lenses, the announcement noted.